Respiratory syncytial virus vaccine: productive development partnership, regulatory and manufacturing advances, and perspectives for the National Immunization Program

Key Points

• This work aims to highlight the progress in developing a vaccine for respiratory syncytial virus and its implications for public health.
• Presentation at the International Symposium on Immunobiologicals
• Focus on vaccine development partnerships
• Overview of regulatory and manufacturing advancements
• Increased collaboration in vaccine development
• Improvements in regulatory processes and manufacturing capabilities
• Enhanced potential for incorporation into the National Immunization Program